Darsalia V, Mansouri S, Ortsater H, Olverling A, Nozadze N, Kappe C, et al
First-line medications in the UK include: Methylphenidate (e.g., Concerta XL, Equasym XL, Medikinet XL)a stimulant that increases dopamine and noradrenaline availability Lisdexamfetamine (Elvanse)a prodrug stimulant for ADHD when significant impairment persists [19] [18] Atomoxetine (Strattera)a non-stimulant noradrenaline reuptake inhibitor, suitable when stimulants are contraindicated or ineffective Guanfacine (Intuniv)a non-stimulant alpha-2 adrenergic agonist licensed for children and adolescents aged 6-17 years Medication choice depends on individual factors including comorbidities (such as anxiety, tics, or substance misuse history), cardiovascular health, and patient preference
Measuring Sleep Efficiency: What Should the Denominator Be
Es ist allerdings nicht grundstzlich unmglich
Ozempic is the stronger choice for weight loss (up to 15% of body weight) and A1C reduction (-1.8%), while Farxiga excels in heart failure prevention (-30% hospitalizations) and chronic kidney disease protection (-39% progression)
Nooms Program By combining individualized titration protocols with daily, appbased behavior change, we aim to support sustainable weight loss with a fraction of the drug exposure and a fraction of the side effects
